Proceeding contribution from Jacqui Lait (Conservative) in the House of Commons on Monday, 19 May 2008. It occurred during Debate on bill and Committee of the Whole House (HC) on Human Fertilisation and Embryology Bill [Lords].
Human Fertilisation and Embryology Bill [Lords]
Can my hon. Friend help me, because I have a slight difficulty with his concept that the expense of the research would mean that few people would be able to benefit from its positive outcomes? He could compare the cost of stem-cell research with that for research in other areas in which some of the basic pharmaceutical companies are already investing, and bear in mind the good taut conservative concept that the price comes down thereafter because the treatment is widely available. Would he perhaps like to draw a parallel with the cost of stem-cell research and its availability to the many hundreds and thousands of people across the world who suffer from these debilitating diseases?
Secondary information
- Type
- Proceeding contribution
- Reference
- 476 c44
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Children Clones Animals Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Donors Genetics Human Fertilisation and Embryology Authority Ethics IVF Foetal tissue Medical treatments Relatives Research Stem cells Human-animal hybrid embryos
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 01:40:53 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474113
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474113
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474113